Chronic levodopa treatment for Parkinson's disease patients is frequently associated with the development of motor complications such as end-of-dose wearing-off and dyskinesias. In this review, we provide an overview of the strategies available for dealing with these problems. Medical management inc
Levodopa-related motor complications—Phenomenology
✍ Scribed by Susan H. Fox; Anthony E. Lang
- Publisher
- John Wiley and Sons
- Year
- 2008
- Tongue
- English
- Weight
- 74 KB
- Volume
- 23
- Category
- Article
- ISSN
- 0885-3185
No coin nor oath required. For personal study only.
✦ Synopsis
Long term levodopa therapy in Parkinson's disease (PD) results in a range of problems. These include fluctuations in FD symptoms termed motor fluctuations, as well as non-motor symptoms, termed non-motor fluctuations. Here we review the phenomenology and methods of assessing these levodopa-related complications.
📜 SIMILAR VOLUMES
## Abstract Reported benefits of various glutamatergic receptor antagonists in Parkinson's disease (PD) prompted an evaluation of the antidyskinetic effect of a putative glutamate release inhibitor in 15 moderately advanced patients. In a 3‐week, double‐blind, proof‐of‐concept study, riluzole (200
cited cases also exhibited sensory loss and neglect. However, their postulated explanation might be plausible only for nondominant hemispheric involvement. In cases like ours, where the lesion involves the dominant hemisphere with no neglect or significant sensory loss, a posterior parietal lesion m
Continuous dopaminergic stimulation (CDS) is a treatment strategy hypothesized to avoid or reduce the motor complications of long-term levodopa therapy, motor fluctuations, and dyskinesia, by preventing or reversing sensitization induced by pulsatile dopaminergic stimulation. The CDS hypothesis is i